Related Experiment Videos
Measuring exhaled nitric oxide in infants during tidal breathing: methodological issues
Peter J Franklin1, Stephen W Turner, Raewyn C Mutch
1Department of Paediatrics, University of Western Australia, Perth, Australia. peterf@ichr.uwa.edu.au
Pediatric Pulmonology
|December 18, 2003
Summary
Measuring fractional exhaled nitric oxide (FeNO) in infants via tidal breathing (TB) has challenges. Ambient NO, sedation, and expiratory flow significantly impact FeNO levels, limiting its use for predicting childhood allergies.
Area of Science:
- Pediatric Allergy and Immunology
- Respiratory Medicine
- Biomarkers
Background:
- Fractional exhaled nitric oxide (FeNO) is a potential biomarker for allergic airway inflammation in children.
- Standardized methods for measuring FeNO in infants using tidal breathing (TB) are lacking.
- Infant FeNO measurement may aid in early identification of children at risk for allergic diseases.
Purpose of the Study:
- To investigate methodological factors affecting tidal breathing FeNO measurements in infants.
- To assess the feasibility of using TB FeNO for identifying infants at risk of allergic disease.
- To compare TB FeNO levels in infants with and without wheeze.
Main Methods:
- Investigated effects of ambient NO, breathing route (oral/nasal), sedation, and tidal expiratory flow on TB FeNO.
- Measured TB FeNO in 88 infants, comparing those with and without wheeze.
- Analyzed data for significant differences and correlations with age and clinical factors.
Main Results:
- Ambient NO >5 ppb significantly altered FeNO readings.
- Sedation significantly impacted FeNO levels (P < 0.001).
- TB FeNO decreased with increasing tidal flow (P < 0.001) and increased with age (P = 0.002).
- No significant difference in FeNO between healthy and wheezy infants, but elevated levels in those with eczema (P = 0.014).
Conclusions:
- Significant methodological limitations exist for measuring TB FeNO in infants.
- Factors like ambient NO, sedation, and expiratory flow require careful control.
- Further standardization is needed before TB FeNO can be reliably used in infant allergy risk assessment.